Company Filing History:
Years Active: 2011
Title: Gabor Wagner: Innovator in Pharmaceutical Chemistry
Introduction
Gabor Wagner is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that target specific receptors in the brain.
Latest Patents
Wagner holds a patent for sulfonyl-quinoline derivatives. This invention relates to new mGluR1 and mGluR5 receptor subtype preferring ligands of formula (I) and/or salts and/or hydrates and/or solvates and/or polymorphs thereof. The patent also encompasses processes and intermediates for their preparation, pharmaceutical compositions containing these compounds, and their use in the treatment and/or prevention of conditions that require modulation of mGluR1 and mGluR5 receptors. He has 1 patent to his name.
Career Highlights
Gabor Wagner is associated with Richter Gedeon Nyrt., a prominent pharmaceutical company in Hungary. His work focuses on innovative solutions that enhance therapeutic options for various medical conditions.
Collaborations
Wagner collaborates with Janos Galambos, contributing to the advancement of research and development in their field.
Conclusion
Gabor Wagner's contributions to pharmaceutical chemistry and his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the treatment of conditions related to mGluR1 and mGluR5 receptors.